aXichem: Exciting Agreement in the Nutraceuticals Segment - Redeye

Redeye endorses aXichem signing a supply and research agreement worth around USD 5m with the Canadian nutrition company, Iovate Health Sciences International Inc., to develop and sell new products containing aXivite in the US and Canada. We continue to foresee a gradually increasing commercial activity during the second half of 2022 and reiterate our Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/846607/axichem-exciting-agreement-in-the-nutraceuticals-segment?utm_source=finwire&utm_medium=RSS